Clinical Trials Directory

Trials / Unknown

UnknownNCT04506229

Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Texas Cardiac Arrhythmia Research Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is a considerable variation in the disease behavior in terms of contracting the infection, manifesting none to a range of symptoms and severity of the infection among individuals exposed to or infected with SARS-CoV-2 virus, the causative organism of COVID-19. Although the respiratory system appears to be the primary target of this virus infection, emerging evidences suggests involvement of extra-pulmonary organs including central nervous system. We aim to compare the genetic profile of individuals with vs without COVID-19 after being exposed to infected cases. Additionally, we will assess the cognitive function in covid-19 positive cases with vs. without neurological symptoms at the time of infection and 1-month follow-up using the Montreal Cognitive Assessment (MoCA) questionnaire.

Conditions

Interventions

TypeNameDescription
GENETICWhole exome sequencingMoCA survey to evaluate cognitive function in COVID-19 positive cases with vs without neurological symptoms

Timeline

Start date
2020-08-20
Primary completion
2021-08-01
Completion
2021-09-01
First posted
2020-08-10
Last updated
2020-08-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04506229. Inclusion in this directory is not an endorsement.